Questionnaire for data collection
Person in charge of human xenotransplantation practice.
Last name :
University of Ferrara School of Medicine
What is the source of your information about human xenotransplantation practices?
What is the therapeutic purpose of this xenotransplantation treatment?
Acute liver failure
Where and when is this human xenotransplantation practice taking place?
Is this treatment part of a clinical trial?
How many patients are included in this clinical trial?
What are the inclusion criteria for patient selection?
i. Duration on the waiting list?
ii. Life-threatening diseases without alternative therapy?
iii. Is a protocol available?
If yes, could you please send a copy?
What is the animal source of the xenotransplantation product?
Do you have information about source animals?
Testing of safety :
Do you have information about testing of safety?
What type of cells/tissues/organs was transplanted?
What type of exposure to xenogeneic cells was involved?
Human cells exposed to xenogeneic Feeder cell:
Other bioartificial isolation device:
Do you have information about transplant recipients?
Have results been presented at a scientific congress?
if yes, where?
Have results been published in a scientific journal?
if yes, where?
Morsiani E et al. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs. 2002; 25:192â€“202
Is this human clinical trial performed with governmental and/or institutional oversight and supervision?
if yes, which?